| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |